Geratherm Medical AG (GME) - Net Assets
Based on the latest financial reports, Geratherm Medical AG (GME) has net assets worth €20.58 Million EUR (≈ $24.06 Million USD) as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€27.53 Million ≈ $32.19 Million USD) and total liabilities (€6.95 Million ≈ $8.13 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check GME strategic asset allocation to assess the company's strategic physical and investment asset allocation.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €20.58 Million |
| % of Total Assets | 74.75% |
| Annual Growth Rate | 1.3% |
| 5-Year Change | 4.51% |
| 10-Year Change | -5.08% |
| Growth Volatility | 11.9 |
Geratherm Medical AG - Net Assets Trend (2002–2024)
This chart illustrates how Geratherm Medical AG's net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see how much is Geratherm Medical AG worth.
Annual Net Assets for Geratherm Medical AG (2002–2024)
The table below shows the annual net assets of Geratherm Medical AG from 2002 to 2024. Also explore Geratherm Medical AG (GME) equity growth momentum to track the company's year-over-year net asset growth rate.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | €20.82 Million ≈ $24.35 Million |
-7.90% |
| 2023-12-31 | €22.61 Million ≈ $26.43 Million |
+1.72% |
| 2022-12-31 | €22.23 Million ≈ $25.99 Million |
+19.30% |
| 2021-12-31 | €18.63 Million ≈ $21.78 Million |
-6.49% |
| 2020-12-31 | €19.93 Million ≈ $23.29 Million |
+3.88% |
| 2019-12-31 | €19.18 Million ≈ $22.42 Million |
-4.70% |
| 2018-12-31 | €20.13 Million ≈ $23.53 Million |
-4.23% |
| 2017-12-31 | €21.02 Million ≈ $24.57 Million |
+2.24% |
| 2016-12-31 | €20.56 Million ≈ $24.03 Million |
-6.30% |
| 2015-12-31 | €21.94 Million ≈ $25.65 Million |
+7.85% |
| 2014-12-31 | €20.34 Million ≈ $23.78 Million |
+1.31% |
| 2013-12-31 | €20.08 Million ≈ $23.48 Million |
+7.84% |
| 2012-12-31 | €18.62 Million ≈ $21.77 Million |
-0.23% |
| 2011-12-31 | €18.66 Million ≈ $21.82 Million |
-9.03% |
| 2010-12-31 | €20.52 Million ≈ $23.99 Million |
+16.11% |
| 2009-12-31 | €17.67 Million ≈ $20.66 Million |
+39.72% |
| 2008-12-31 | €12.65 Million ≈ $14.79 Million |
-22.19% |
| 2007-12-31 | €16.25 Million ≈ $19.00 Million |
-6.84% |
| 2006-12-31 | €17.45 Million ≈ $20.40 Million |
+1.90% |
| 2005-12-31 | €17.12 Million ≈ $20.02 Million |
+2.08% |
| 2004-12-31 | €16.77 Million ≈ $19.61 Million |
+1.83% |
| 2003-12-31 | €16.47 Million ≈ $19.26 Million |
+4.99% |
| 2002-12-31 | €15.69 Million ≈ $18.34 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Geratherm Medical AG's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 20192900.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | €5.41 Million | 25.74% |
| Other Comprehensive Income | €649.74K | 3.09% |
| Other Components | €15.16 Million | 72.13% |
| Total Equity | €21.02 Million | 100.00% |
Geratherm Medical AG Competitors by Market Cap
The table below lists competitors of Geratherm Medical AG ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Macompta Fr Sa
PA:MLMCA
|
$15.50 Million |
|
Seoul Pharma Co. Ltd
KQ:018680
|
$15.52 Million |
|
DT&C Co. Ltd
KQ:187220
|
$15.53 Million |
|
Sapura Industrial Bhd
KLSE:7811
|
$15.53 Million |
|
Volution Group plc
LSE:FAN
|
$15.50 Million |
|
Deltamac Taiwan Co Ltd
TWO:6144
|
$15.49 Million |
|
Mobix Labs Inc
NASDAQ:MOBX
|
$15.49 Million |
|
Alexium International Group Ltd
AU:AJX
|
$15.49 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Geratherm Medical AG's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 22,331,844 to 21,022,189, a change of -1,309,655 (-5.9%).
- Net income of 705,172 contributed positively to equity growth.
- Dividend payments of 541,000 reduced retained earnings.
- Other comprehensive income increased equity by 123,203.
- Other factors decreased equity by 1,597,030.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €705.17K | +3.35% |
| Dividends Paid | €541.00K | -2.57% |
| Other Comprehensive Income | €123.20K | +0.59% |
| Other Changes | €-1.60 Million | -7.6% |
| Total Change | €- | -5.86% |
Book Value vs Market Value Analysis
This analysis compares Geratherm Medical AG's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.63x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2002-12-31 | €3.49 | €2.45 | x |
| 2003-12-31 | €3.68 | €2.45 | x |
| 2004-12-31 | €3.71 | €2.45 | x |
| 2005-12-31 | €3.79 | €2.45 | x |
| 2006-12-31 | €3.88 | €2.45 | x |
| 2007-12-31 | €3.61 | €2.45 | x |
| 2008-12-31 | €2.80 | €2.45 | x |
| 2009-12-31 | €3.93 | €2.45 | x |
| 2010-12-31 | €4.17 | €2.45 | x |
| 2011-12-31 | €3.85 | €2.45 | x |
| 2012-12-31 | €3.85 | €2.45 | x |
| 2013-12-31 | €4.18 | €2.45 | x |
| 2014-12-31 | €4.18 | €2.45 | x |
| 2015-12-31 | €4.55 | €2.45 | x |
| 2016-12-31 | €4.30 | €2.45 | x |
| 2017-12-31 | €4.25 | €2.45 | x |
| 2018-12-31 | €4.10 | €2.45 | x |
| 2019-12-31 | €4.01 | €2.45 | x |
| 2020-12-31 | €4.10 | €2.45 | x |
| 2021-12-31 | €3.74 | €2.45 | x |
| 2022-12-31 | €4.10 | €2.45 | x |
| 2023-12-31 | €4.13 | €2.45 | x |
| 2024-12-31 | €3.88 | €2.45 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Geratherm Medical AG utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 3.35%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 3.45%
- • Asset Turnover: 0.72x
- • Equity Multiplier: 1.36x
- Recent ROE (3.35%) is below the historical average (5.68%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2002 | 6.08% | 13.14% | 0.38x | 1.21x | €-615.09K |
| 2003 | 9.46% | 20.08% | 0.41x | 1.16x | €-88.84K |
| 2004 | 7.98% | 17.23% | 0.41x | 1.13x | €-338.35K |
| 2005 | 8.36% | 16.87% | 0.46x | 1.09x | €-279.06K |
| 2008 | -23.19% | -27.21% | 0.71x | 1.20x | €-4.18 Million |
| 2009 | 15.16% | 17.96% | 0.66x | 1.28x | €911.81K |
| 2010 | 12.33% | 14.30% | 0.59x | 1.45x | €480.60K |
| 2011 | 5.75% | 5.77% | 0.77x | 1.29x | €-810.69K |
| 2012 | 6.27% | 7.34% | 0.59x | 1.44x | €-709.22K |
| 2013 | 6.44% | 7.83% | 0.59x | 1.39x | €-736.69K |
| 2014 | 8.12% | 8.99% | 0.66x | 1.38x | €-388.54K |
| 2015 | 12.00% | 12.51% | 0.71x | 1.34x | €450.42K |
| 2016 | 10.52% | 10.14% | 0.78x | 1.34x | €110.69K |
| 2017 | 3.23% | 3.23% | 0.74x | 1.35x | €-1.42 Million |
| 2018 | 5.68% | 5.36% | 0.73x | 1.45x | €-878.37K |
| 2019 | 1.46% | 1.46% | 0.60x | 1.68x | €-1.69 Million |
| 2020 | 10.07% | 7.45% | 0.76x | 1.77x | €15.17K |
| 2021 | 0.66% | 0.50% | 0.71x | 1.87x | €-1.73 Million |
| 2022 | 4.58% | 3.96% | 0.67x | 1.72x | €-1.21 Million |
| 2023 | 4.98% | 5.30% | 0.59x | 1.60x | €-1.12 Million |
| 2024 | 3.35% | 3.45% | 0.72x | 1.36x | €-1.40 Million |
Industry Comparison
This section compares Geratherm Medical AG's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $37,307,353,473
- Average return on equity (ROE) among peers: -16.76%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Geratherm Medical AG (GME) | €20.58 Million | 6.08% | 0.34x | $15.50 Million |
| LEPU MED.T.B. SP.GDR O.N. (07Z0) | $17.76 Billion | 5.42% | 0.47x | $157.40K |
| BIORETEC OY (0TN) | $9.74 Million | -47.38% | 0.18x | $16.10 Million |
| SYSMEX CORP.UNSP.ADR 1/2 (0YX0) | $349.05 Billion | 12.63% | 0.39x | $4.70 Billion |
| INMODE LTD IS -01 (154) | $703.81 Million | 25.76% | 0.12x | $711.77 Million |
| HeraMED Limited (1I4) | $-105.98K | 0.00% | 0.00x | $28.30 Million |
| Medtronic PLC (2M6) | $1.33 Billion | 22.02% | 0.46x | $83.04 Billion |
| Peijia Medical Limited (4WO) | $1.86 Billion | -10.94% | 0.43x | $401.71 Million |
| AVITA Medical Inc (51KB) | $20.86 Million | -118.03% | 0.23x | $172.49 Million |
| BRAINCOOL AB (5YL) | $111.74 Million | -54.84% | 0.19x | $18.88 Million |
| MICROPORT CARDIO.MEDTECH. (72X) | $2.22 Billion | -2.23% | 0.20x | $107.57 Million |
About Geratherm Medical AG
Geratherm Medical AG operates as a medical technology company in Germany. It operates through Healthcare Diagnostic, Respiratory, Cardio/Stroke, and Medical Warming Systems segments. The Healthcare Diagnostic segment provides clinical thermometers; and blood pressure monitors. The Respiratory segment develops and manufactures products primarily for pulmonary and cardiopulmonary function diagnosti… Read more